TRAV30 (Gene)

Organism:

Homo sapiens

Taxonomy (Entity type)

Synonyms:ENTREZ:28652, HGNC:12129, T cell receptor alpha variable 30, TCRAV29S1, TCRAV30S1, TRAV30

Id:ENSG00000259092

Entrez:28652

Ensembl:ENSG00000259092

Description:T cell receptor alpha variable 30

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TRAV30's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TRAV30.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TRAV30.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TRAV30.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TRAV30.

Results found

Linked to

	Label	Description
	GSE182680 GSE182683 dexamethasone 5 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE140758 MDM2 inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE189772 GSE189773 CTB CTBp 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE189772 GSE189773 MHC FBXO11 inhibition CTBp 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE140758 MDM2 inhibition 0 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 5 v 11 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE140758 MDM2 inhibition 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE239844 crizotinib 6 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 8 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE189772 GSE189773 CTB CTBp 3 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE189772 GSE189773 MHC FBXO11 inhibition CTBp 3 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 7 v 8 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE140758 MDM2 inhibition 0 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 3 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.